目的:通过研究肝脏少见原发恶性肿瘤临床病理的特点,以提高该类型肿瘤的诊疗水平。方法:收集我院肝胆外科自2003年1月至2012年12月经病理确诊的肝脏少见原发恶性肿瘤24例,其中经外科手术治疗20例,穿刺活检4例,结合文献对其临床及病理特点进行分析总结。结果:此组共24例,占同期全部肝脏恶性肿瘤病例的2.75%(24/874),涵盖13种病理类型:肝母细胞瘤5例,神经内分泌瘤4例,淋巴瘤3例,胆管黏液腺癌2例,恶性神经鞘瘤2例,恶性神经束膜瘤1例,上皮样血管内皮瘤1例,上皮样血管肌肉脂肪瘤1例,多形肉瘤1例,癌肉瘤1例,平滑肌肉瘤1例,梭形细胞瘤1例,鳞癌1例。男女比例2∶1(16∶8)。平均年龄48.90岁(6~74岁,中位年龄51岁)。该组患者术后1年和5年生存率分别为49.0%和26.1%。结论:肝脏少见原发性恶性肿瘤临床诊断和鉴别困难,手术切除或穿刺活检的标本行免疫病理检查是诊断疾病的金标准。治疗尽量根治切除并按照指南辅助有效化疗或进行靶向治疗。
Objective:To investigate the clinicopathologic characteristics of rare primary liver malignant tumor, im- proving the accuracy of diagnosis and treatment level. Methods:24 cases of rare primary liver malignant tumor (20 cases underwent surgical resection,4 cases underwent biopsy) which were confirmed by histopathology and immuno- histoehemistry,were collected in our hospital from Jan. 2003 to Dec. 2012. A retrospective analysis was made on these cases combined with literature. Results:Rare primary malignant liver tumor accounted for 2.75% (24/874) of all ca- ses of primary liver tumor over the same period, including 13 kinds of pathology : Hepatoblastoma ( n = 5 ), neuroendo- crine neoplasms ( n = 4), lymphoma ( n = 3 ), cholangiocarcinoma ( n = 2), malignant neurilemmoma ( n = 2), malig- nant perineurioma ( n = 1 ), epitheliod hemangioendothelioma ( n = 1 ), mucinous epithelioid angiomyolipoma ( n = 1 ),pleomorphic sarcoma ( n = 1 ), carcinosarcoma ( n = 1 ), leiomyosarcoma ( n = 1 ), spindle cell carcinoma ( n -- 1 ), squamous cell carcinoma ( n = 1 ). In this group, the ratio of male to female was 2:1 ( 16: 8), with a mean age of 48.90 years old (6 ~74 years old,a median age of S1 years old). The 1 and 5 years postoperative survival rate were 49.0% and 26.1%. Conclusion:It is difficult to make a clinical diagnosis on rare primary malignant liver tumor. Specimens from surgical resection or biopsy for immune pathology examination are the gold standard for diagnosis. Radical resec- tion and effective chemotherapy or tar~etin~ theraDv accordin~ to ~uidalin,= ~r,~ n,~,. +~+~+